Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Condition(s):Glioblastoma Multiforme; Glioblastoma; GBM; Grade IV Astrocytoma; Glioma; Brain Cancer; Brain TumorLast Updated:May 18, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Glioblastoma Multiforme; Glioblastoma; GBM; Grade IV Astrocytoma; Glioma; Brain Cancer; Brain TumorLast Updated:May 18, 2022Active, not recruiting
Condition(s):Renal Cell CarcinomaLast Updated:March 8, 2011Unknown status
Condition(s):Renal NeoplasmaLast Updated:July 1, 2015Not yet recruiting
Condition(s):Metastatic MelanomaLast Updated:July 6, 2023Not yet recruiting
Condition(s):Advanced MelanomaLast Updated:July 6, 2023Not yet recruiting
Condition(s):Malignant Melanoma; Adjuvant Drug Therapy; Vaccin TherapyLast Updated:April 22, 2020Terminated
Condition(s):Malignant GliomaLast Updated:December 3, 2010Unknown status
Condition(s):Advanced Renal Cell CarcinomaLast Updated:November 23, 2011Completed
Condition(s):Advanced MelanomaLast Updated:April 26, 2010Completed
Condition(s):Non Small Cell Lung CancerLast Updated:March 20, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.